Table 1. Correlation of CCL14 mRNA expression and prognosis in hepatocellular carcinoma with different clinicopathological factors by Kaplan-Meier plotter.

Clinicopathological factors	Overall survival				Progression-free survival
	N	Hazard ratio	P-value		N	Hazard ratio	P-value
SEX
Female	118	0.59(0.34-1.03)	0.061		120	0.7(0.42-1.16)	0.16
Male	246	0.37(0.23-0.6)	1.8e-05		246	0.56(0.39-0.8)	0.0013
Stage
1	170	0.45(0.24-0.86)	0.014		171	0.91(0.55-1.49)	0.69
2	83	0.39(0.17-0.9)	0.023		85	0.74(0.41-1.33)	0.31
1+2	253	0.52(0.32-0.85)	0.0074		256	0.64(0.44-0.93)	0.019
3	83	0.45(0.25-0.82)	0.0075		85	1(0.58-1.72)	1
4	5	-	-		5	-	-
3+4	87	0.5(0.28-0.89)	0.016		90	1.03(0.61-1.74)	0.92
Grade
1	55	0.67(0.26-1.72)	0.4		55	0.89(0.4-1.95)	0.77
2	174	0.52(0.31-0.87)	0.012		175	0.57(0.37-0.88)	0.01
3	118	0.39(0.21-0.75)	0.003		119	0.74(0.45-1.21)	0.23
4	12	-	-		12	-	-
AJCC_T
1	180	0.48(0.26-0.89)	0.017		180	0.86(0.53-1.39)	0.54
2	90	0.35(0.16-0.76)	0.0059		92	0.68(0.4-1.18)	0.17
3	78	0.47(0.26-0.86)	0.012		78	1(0.57-1.77)	0.99
4	13	-	-		13	-	-
Vascular invasion
yes	90	0.46(0.21-1.02)	0.05		91	0.73(0.42-1.29)	0.28
None	203	0.46(0.27-0.78)	0.0033		204	0.68(0.44-1.06)	0.088
Race
White	181	0.66(0.41-1.04)	0.071		183	0.62(0.41-0.92)	0.016
Asian	155	0.3(0.16-0.58)	0.00015		155	0.61(0.38-0.98)	0.04
Alcohol consumption
yes	115	0.52(0.27-1.0)	0.0048		115	0.5(0.3-0.85)	0.0088
none	202	0.53(0.33-0.85)	0.0068		204	0.66(0.44-0.99)	0.042
Virus hepatitis
Yes	150	0.68(0.35-1.29)	0.23		152	0.65(0.41-1.04)	0.068
None	167	0.38(0.24-0.62)	4.1e-05		167	0.44(0.28-0.69)	0.00021

Bold values indicate P < 0.05.